U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Increased urinary porphobilinogen

MedGen UID:
868601
Concept ID:
C4023000
Finding
HPO: HP:0012217

Definition

The concentration of porphobilinogen in the urine, normalized for urine concentration, is above the upper limit of normal. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVIncreased urinary porphobilinogen

Conditions with this feature

Hereditary coproporphyria
MedGen UID:
57931
Concept ID:
C0162531
Disease or Syndrome
Hereditary coproporphyria (HCP) is an acute (hepatic) porphyria in which the acute symptoms are neurovisceral and occur in discrete episodes. Attacks typically start in the abdomen with low-grade pain that slowly increases over a period of days (not hours) with nausea progressing to vomiting. In some individuals, the pain is predominantly in the back or extremities. When an acute attack is untreated, a motor neuropathy may develop over a period of days or a few weeks. The neuropathy first appears as weakness proximally in the arms and legs, then progresses distally to involve the hands and feet. Some individuals experience respiratory insufficiency due to loss of innervation of the diaphragm and muscles of respiration. Acute attacks are associated commonly with use of certain medications, caloric deprivation, and changes in female reproductive hormones. About 20% of those with an acute attack also experience photosensitivity associated with bullae and skin fragility.
Variegate porphyria
MedGen UID:
58118
Concept ID:
C0162532
Disease or Syndrome
Variegate porphyria (VP) is both a cutaneous porphyria (with chronic blistering skin lesions) and an acute porphyria (with severe episodic neurovisceral symptoms). The most common manifestation of VP is adult-onset cutaneous blistering lesions (subepidermal vesicles, bullae, and erosions that crust over and heal slowly) of sun-exposed skin, especially the hands and face. Other chronic skin findings include milia, scarring, thickening, and areas of decreased and increased skin pigmentation. Facial hyperpigmentation and hypertrichosis may occur. Cutaneous manifestations may improve in winter and be less prevalent in northern regions and in dark-skinned individuals. Acute neurovisceral symptoms can occur any time after puberty, but less often in the elderly. Acute manifestations are highly variable, but may be similar from episode to episode in a person with recurrent attacks; not all manifestations are present in a single episode; and acute symptoms may become chronic. Symptoms are more common in women than men. The most common manifestations are abdominal pain; constipation; pain in the back, chest, and extremities; anxiety; seizures; and a primarily motor neuropathy resulting in muscle weakness that may progress to quadriparesis and respiratory paralysis. Psychiatric disturbances and autonomic neuropathy can also be observed. Acute attacks may be severe and are potentially fatal.
Harderoporphyria
MedGen UID:
137981
Concept ID:
C0342859
Disease or Syndrome
Harderoporphyria (HARPO) is a rare erythropoietic variant form of hereditary coproporphyria (HCP; 121300) characterized by neonatal hemolytic anemia, sometimes accompanied by skin lesions, and massive excretion of harderoporphyrin in feces. During childhood and adulthood, a mild residual anemia is chronically observed (review by Schmitt et al., 2005).

Professional guidelines

PubMed

Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ
Ann Intern Med 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. PMID: 15767622

Recent clinical studies

Etiology

Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ
Ann Intern Med 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. PMID: 15767622

Diagnosis

Jaramillo-Calle DA, Martinez YA, Balwani M, Fernandez C, Toro M
Mol Genet Metab 2021 Jul;133(3):242-249. Epub 2021 May 7 doi: 10.1016/j.ymgme.2021.04.008. PMID: 34083144
Bonkovsky HL
Hematology Am Soc Hematol Educ Program 2005:24-30. doi: 10.1182/asheducation-2005.1.24. PMID: 16304355
Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ
Ann Intern Med 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. PMID: 15767622
Holman JR, Green JB
Postgrad Med 1989 Oct;86(5):295-8. doi: 10.1080/00325481.1989.11704454. PMID: 2678070

Therapy

Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ
Ann Intern Med 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. PMID: 15767622

Prognosis

Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, Desnick RJ
Ann Intern Med 2005 Mar 15;142(6):439-50. doi: 10.7326/0003-4819-142-6-200503150-00010. PMID: 15767622

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...